Mylan announced FDA approval and the availability of premixed levetiracetam supplied in ready-to-administer bags of sodium chloride injection. The premixed levetiracetam will be supplied in three dosage strengths: 500mg/100mL (levetiracetam in 0.82% sodium chloride injection), 1,000mg/100mL (levetiracetam in 0.75% sodium chloride injection), and 1,500mg/100mL (levetiracetam in 0.54% sodium chloride injection). The premixed drug may be stored at room temperature.
Levetiracetam is indicated as an adjunct in patient onset seizures when oral administration is temporarily not feasible.
For more information call (800) RX-MYLAN or visit www.premixedleve.com.